Ivanova, E.,
Asadullina, D.,
Rakhimov, R.,
Izmailov, A.,
Izmailov, Al.,
Gilyazova, G.,
Galimov, Sh.,
Pavlov, V.,
Khusnutdinova, E.,
Gilyazova, I. (2022) renal cell carcinoma (ccRCC) patients with different clinical response to ICIs (nivolumab) and treatment
Ivanova, E.,
Gilyazova, I.,
Pavlov, V.,
Izmailov, A.,
Gimalova, G.,
Karunas, A.,
Prokopenko, I.,
Khusnutdinova, E. (2022) risk of developing disease outcomes from the general population. Clear cell
renal cell carcinoma (cc
Buzaev, IV,
Plechev, VV,
Khalikova, G,
Khabirova, K,
Nikolaeva, IE,
Onorato, EM (2022) . After heart team discussion, with the aim to reduce the risk of
embolization, an innovative stent
-eclampsia/eclampsia,
renal failure, cytotoxic agents and autoimmune conditions. The mechanism underlying PRES is not certain